Investor Relations
Featured Event
Feb 4, 2010 at 1:00 PM ET
Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trial
Feb 9, 2010 at 11:30 AM ET
BIO CEO Investor Conference
Spectrum Pharmaceuticals is a commercial-stage biotechnology company with a focus in oncology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.
Spectrum Pharmaceuticals’ stock is traded through the Nasdaq Global Market System
Ticker Symbol: SPPI
|
| Stock Information |
NASDAQ:SPPI
$4.36
- 0.03
|
Feb 8, 2010
4:00 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
| Search Investor Relations |
|
|